Drug shortage
Dexmedetomidine Hydrochloride Injection · Par Pharmaceutical, Inc.
FDA drug shortage · Current · updated Apr 1, 2025
Key facts
| Generic name | Dexmedetomidine Hydrochloride Injection |
|---|---|
| Proprietary name | Dexmedetomidine Hydrochloride |
| Company | Par Pharmaceutical, Inc. |
| Presentation | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) |
| Dosage form | Injection |
| Strength | 4 ug/1 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Anesthesia |
| Package NDCs | 42023-186-20 |
| First posted | Apr 10, 2020 |
| Last updated | Apr 1, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: